iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 5,546 shares, a growth of 308.4% from the May 14th total of 1,358 shares. Approximately 3.7% of the shares of the stock are sold short. Based on an average trading volume of 1,205 shares, the days-to-cover ratio is presently 4.6 days.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of NYSEARCA:IBRN opened at $34.83 on Friday. The company’s 50 day simple moving average is $34.67 and its 200 day simple moving average is $32.95. The stock has a market capitalization of $5.22 million, a price-to-earnings ratio of 15.61 and a beta of 0.77. iShares Neuroscience and Healthcare ETF has a 1 year low of $21.78 and a 1 year high of $37.00.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.